Financial Performance - For the six months ended June 30, 2023, the group achieved a total revenue of RMB 185,915,928, a decrease of 9.40% compared to RMB 205,210,475 for the same period in 2022[4] - The gross profit for the same period was RMB 6,848,825, representing a decline of 33.96% from RMB 10,370,957 in the previous year[4] - The loss attributable to equity holders of the company was RMB 11,250,040, an improvement from a loss of RMB 13,248,062 in the prior year[4] - The basic loss per share for the period was RMB 0.594, compared to RMB 0.699 for the same period last year[4] - The company's comprehensive gross profit for the same period was RMB 6,848,825, a year-on-year decrease of 33.96% from RMB 10,370,957 in 2022, resulting in a gross profit margin of 3.68% compared to 5.05% in the previous year[32] Assets and Liabilities - The total assets as of June 30, 2023, amounted to RMB 326,577,334, down from RMB 337,196,239 at the end of 2022[6] - Current liabilities totaled RMB 221,585,923, compared to RMB 218,249,273 at the end of 2022, indicating a slight increase[7] - The net asset value of the company was RMB 69,757,798, a decrease from RMB 83,713,353 at the end of the previous year[7] - The net receivables from trade accounts as of June 30, 2023, were RMB 20,359,441, down from RMB 31,866,638 as of December 31, 2022, reflecting a decrease of 36.1%[19] - The company's prepayments and other receivables totaled RMB 61,312,181 as of June 30, 2023, down from RMB 77,654,553 as of December 31, 2022, a decrease of 21.1%[20] - The group's debt-to-asset ratio was 0.79 as of June 30, 2023, compared to 0.75 as of December 31, 2022[38] Cash Flow and Investments - Operating cash flow for the six months ended June 30, 2023, was RMB 3,102,287, compared to a cash outflow of RMB 18,428,270 in the same period of 2022[6] - The net cash used in investing activities for the six months ended June 30, 2023, was RMB 1,288,270, compared to RMB 3,198,037 in the same period of 2022, indicating a decrease of 59.7%[6] - The company invested approximately RMB 461,949 in property, plant, and equipment during the period, significantly lower than RMB 1,428,453 in the same period of 2022[17] Expenses - Research and development expenses for the period were RMB 13,773,232, compared to RMB 12,242,150 in the previous year, indicating increased investment in R&D[5] - The company's income tax expense for the six months ended June 30, 2023, was RMB -41,394, compared to RMB 146,275 in the same period of 2022, indicating a reduction in tax liability[14] - The group's sales and distribution costs for the six months ended June 30, 2023, were RMB 5,277,328, a decrease of 35.00% compared to RMB 8,118,740 for the same period in 2022[33] - Research and administrative expenses increased by 12.51% to RMB 13,773,232 for the six months ended June 30, 2023, compared to RMB 12,242,150 in the same period of 2022[34] - Financing costs decreased by 54.32% to RMB 1,521,452 for the six months ended June 30, 2023, down from RMB 3,330,598 in the same period of 2022[35] Dividends - The company did not recommend the payment of any dividend for the six months ended June 30, 2023[4] - The company has not proposed an interim dividend for the six months ended June 30, 2023, consistent with no dividend declared for the same period in 2022[26] - The company did not declare any interim dividend for the six months ending June 30, 2023[58] Business Operations - The company is involved in two main business areas: bio-composite fertilizers and elderly care services, focusing on the integration of medical and elderly care services[28] - The company has strengthened its market sales management and adjusted product structure in response to market conditions, aiming to stabilize its bio-composite fertilizer business[29] - The company has expanded its elderly health resource allocation business, including the rental of assistive devices and the sale of elderly food products[31] - The aging population in China, with 280 million people aged 60 and above, presents significant opportunities for the elderly care services sector, which the group aims to develop further[43] - The group has developed elderly health resource allocation services, including assistive device rentals and elderly food sales, with plans to expand into more categories[43] Governance and Management - The audit committee reviewed the interim results and report for the six months ending June 30, 2023[52] - No new share option schemes were approved during the first half of 2023[53] - The company did not purchase, sell, or redeem any of its shares during the review period[56] - The company has not entered into any management contracts for its overall business or any major business during the first half of 2023[54] - The board of directors and management are committed to implementing the corporate governance code as per GEM listing rules[57] - There were no reported conflicts of interest or competition with the company's business as of June 30, 2023[50] - The company is currently led by co-CEOs Sun Li and Qin Wenhua, with Sun also serving as the chairperson[57] - The company maintains a focus on transparency and effective internal controls in its governance practices[57] Shareholder Information - As of June 30, 2023, major shareholders include Tianjin Economic and Technological Development Zone State-owned Assets Management Co., Ltd. with 182,500,000 shares (9.63%), Xiangyong Investment with 180,000,000 shares (9.50%), and Guangdong Jiamei Ecological Technology Co., Ltd. with 180,000,000 shares (9.50%)[48]
泰达生物(08189) - 2023 - 中期财报